Understanding Bcma Targeted Therapies In Multiple Myeloma
If you are looking for information about Bcma Targeted Therapies In Multiple Myeloma, you have come to the right place. Review of
Key Takeaways about Bcma Targeted Therapies In Multiple Myeloma
- Co-Chairs, Thomas G. Martin, III, MD, and Krina Patel, MD, MSc, discuss
- Carlos Fernandez de Larrea, MD, PhD, University of Barcelona, Barcelona, Spain, discusses the challenges associated with ...
- Yu-Tzu Tai, PhD, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, comments on the potential of γ-secretase ...
- In this episode, Suzanne Lentzsch, MD, Ph.D., and Joseph Mikhael, MD, MEd, FRCPC, FACP, discuss the role of
- Watch the full course and our most up-to-date content here: https://linktr.ee/HealthTreeUniversity Create a free account to track ...
Detailed Analysis of Bcma Targeted Therapies In Multiple Myeloma
Experts discuss how they would choose between the Peter Voorhees, MD of the Levine Cancer Institute in Charlotte NC discusses the emerging treatments for Niels van de Donk, MD, PhD, VU University Medical Center, Amsterdam, Netherlands, discusses the downregulation of B-cell ...
Rakesh Popat, BSc, MBBS, MRCP, FRCPath, PhD, University College London Hospitals, London, UK, provides an insight into the ...
We hope this detailed breakdown of Bcma Targeted Therapies In Multiple Myeloma was helpful.
